Clinical Trial Update: European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study

View source ↗

Summary

Clinical trial update for the European Ankylosing Spondylitis Infliximab Cohort (EASIC) follow-up registration study; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Rheumazentrum Ruhrgebiet | Conditions: Ankylosing Spondylitis | Status: UNKNOWN